Digitalis intoxication induced by paroxetine co-administration

Lancet

Volumn 368, Issue 9551, 2006, Pages 1963-

  Hallberg, Pär ^a   Melhus, Håkan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CREATININE; DIGOXIN; GLYCOPROTEIN P; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CREATININE BLOOD LEVEL; DEHYDRATION; DIGOXIN BLOOD LEVEL; DISEASE EXACERBATION; DRUG HALF LIFE; DRUG INTOXICATION; DRUG MEGADOSE; DRUG OVERDOSE; HUMAN; KIDNEY FAILURE; LETTER; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; STEADY STATE; VOMITING;

EID: 33751438531     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69803-6     Document Type: Letter

References (5)

1. Yasui-Furukori N., and Kaneko S. Digitalis intoxication induced by paroxetine co-administration. Lancet 367 (2006) 788
2. Weiss J., Dorman S., Martin-Facklam M., et al. Inhibition of P-glycoprotein by newer antidepressants. J Pharmacol Exp Ther 305 (2003) 197-204
3. Ochs H., Greenblatt D., Verburg-Ochs B., et al. Chronic treatment with fluvoxamine, clovoxamine, and placebo: interaction with digoxin and effects on sleep and alertness. J Clin Pharmacol 29 (1989) 91-95
4. Rapeport W., Coates P., Dewland P., et al. Absence of sertraline-mediated effect on digoxin pharmacokinetics and electrocardiographic findings. J Clin Psychiatry 57 suppl 1 (1996) 16-19
5. Juurlink D., Mamdani M., Kopp A., et al. A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin. Br J Clin Pharmacol 59 (2005) 102-107